Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma
Clinical trial NCT02203864 · COMPLETED
Trial details
- NCT number
- NCT02203864
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 2001-02-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.